Related Experiment Video
Updated: Dec 7, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
COVID-19 and the kidney
Mohamed Hassanein1, Yeshwanter Radhakrishnan2, John Sedor3
1Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic.
Abstract:
COVID-19 is primarily considered a respiratory illness, but the kidney may be one of the targets of SARS-CoV-2 infection, since the virus enters cells through the angiotensin-converting enzyme 2 receptor, which is found in abundance in the kidney. Information on kidney involvement in COVID-19 is limited but is evolving rapidly. This article discusses the pathogenesis of acute kidney injury (AKI) in COVID-19, its optimal management, and the impact of COVID-19 on patients with chronic kidney disease, patients with end-stage kidney disease on dialysis, and kidney transplant recipients.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can affect the kidneys, leading to acute kidney injury (AKI). This review covers kidney damage mechanisms, management strategies, and impacts on various kidney patient groups during the COVID-19 pandemic.
Area of Science:
- Nephrology
- Virology
- Infectious Diseases
Background:
- COVID-19, primarily a respiratory illness, shows significant kidney involvement.
- The SARS-CoV-2 virus utilizes the angiotensin-converting enzyme 2 receptor, abundant in kidneys, for cell entry.
- Current understanding of kidney pathology in COVID-19 is rapidly evolving.
Purpose of the Study:
- To elucidate the pathogenesis of acute kidney injury (AKI) in COVID-19 patients.
- To outline optimal management strategies for kidney complications associated with COVID-19.
- To assess the impact of COVID-19 on patients with pre-existing kidney conditions.
Main Methods:
- Review of current literature on SARS-CoV-2 and kidney pathology.
- Discussion of viral entry mechanisms into renal cells.
- Analysis of clinical data regarding AKI in COVID-19.
Main Results:
- SARS-CoV-2 infection can lead to AKI through various mechanisms.
- Management requires tailored approaches based on patient's kidney status.
- COVID-19 poses risks to patients with chronic kidney disease, end-stage kidney disease on dialysis, and transplant recipients.
Conclusions:
- Kidney involvement is a critical aspect of COVID-19, necessitating focused clinical attention.
- Effective management of AKI and protection of vulnerable kidney patient populations are paramount.
- Further research is crucial to fully understand and mitigate the renal consequences of SARS-CoV-2 infection.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction

